111 related articles for article (PubMed ID: 28435024)
1. Lkb1 deletion in murine B lymphocytes promotes cell death and cancer.
Souroullas GP; Fedoriw Y; Staudt LM; Sharpless NE
Exp Hematol; 2017 Jul; 51():63-70.e1. PubMed ID: 28435024
[TBL] [Abstract][Full Text] [Related]
2. STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment.
Koyama S; Akbay EA; Li YY; Aref AR; Skoulidis F; Herter-Sprie GS; Buczkowski KA; Liu Y; Awad MM; Denning WL; Diao L; Wang J; Parra-Cuentas ER; Wistuba II; Soucheray M; Thai T; Asahina H; Kitajima S; Altabef A; Cavanaugh JD; Rhee K; Gao P; Zhang H; Fecci PE; Shimamura T; Hellmann MD; Heymach JV; Hodi FS; Freeman GJ; Barbie DA; Dranoff G; Hammerman PS; Wong KK
Cancer Res; 2016 Mar; 76(5):999-1008. PubMed ID: 26833127
[TBL] [Abstract][Full Text] [Related]
3. Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas.
Contreras CM; Gurumurthy S; Haynie JM; Shirley LJ; Akbay EA; Wingo SN; Schorge JO; Broaddus RR; Wong KK; Bardeesy N; Castrillon DH
Cancer Res; 2008 Feb; 68(3):759-66. PubMed ID: 18245476
[TBL] [Abstract][Full Text] [Related]
4. LKB1 deficiency sensitizes mice to carcinogen-induced tumorigenesis.
Gurumurthy S; Hezel AF; Sahin E; Berger JH; Bosenberg MW; Bardeesy N
Cancer Res; 2008 Jan; 68(1):55-63. PubMed ID: 18172296
[TBL] [Abstract][Full Text] [Related]
5. Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation.
Bardeesy N; Sinha M; Hezel AF; Signoretti S; Hathaway NA; Sharpless NE; Loda M; Carrasco DR; DePinho RA
Nature; 2002 Sep; 419(6903):162-7. PubMed ID: 12226664
[TBL] [Abstract][Full Text] [Related]
6. Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma.
Guldberg P; thor Straten P; Ahrenkiel V; Seremet T; Kirkin AF; Zeuthen J
Oncogene; 1999 Mar; 18(9):1777-80. PubMed ID: 10208439
[TBL] [Abstract][Full Text] [Related]
7. Lkb1 inactivation is sufficient to drive endometrial cancers that are aggressive yet highly responsive to mTOR inhibitor monotherapy.
Contreras CM; Akbay EA; Gallardo TD; Haynie JM; Sharma S; Tagao O; Bardeesy N; Takahashi M; Settleman J; Wong KK; Castrillon DH
Dis Model Mech; 2010; 3(3-4):181-93. PubMed ID: 20142330
[TBL] [Abstract][Full Text] [Related]
8. The serine/threonine kinase LKB1 controls thymocyte survival through regulation of AMPK activation and Bcl-XL expression.
Cao Y; Li H; Liu H; Zheng C; Ji H; Liu X
Cell Res; 2010 Jan; 20(1):99-108. PubMed ID: 20029389
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.
Sanchez-Cespedes M; Parrella P; Esteller M; Nomoto S; Trink B; Engles JM; Westra WH; Herman JG; Sidransky D
Cancer Res; 2002 Jul; 62(13):3659-62. PubMed ID: 12097271
[TBL] [Abstract][Full Text] [Related]
10. LKB1 mutation in large cell carcinoma of the lung.
Zhong D; Guo L; de Aguirre I; Liu X; Lamb N; Sun SY; Gal AA; Vertino PM; Zhou W
Lung Cancer; 2006 Sep; 53(3):285-94. PubMed ID: 16822578
[TBL] [Abstract][Full Text] [Related]
11. Tp53 deletion in B lineage cells predisposes mice to lymphomas with oncogenic translocations.
Rowh MA; DeMicco A; Horowitz JE; Yin B; Yang-Iott KS; Fusello AM; Hobeika E; Reth M; Bassing CH
Oncogene; 2011 Nov; 30(47):4757-64. PubMed ID: 21625223
[TBL] [Abstract][Full Text] [Related]
12. Specific deletion of LKB1/
George JW; Patterson AL; Tanwar PS; Kajdacsy-Balla A; Prins GS; Teixeira JM
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3445-3450. PubMed ID: 28289208
[TBL] [Abstract][Full Text] [Related]
13. Homozygous deletion of the STK11/LKB1 locus and the generation of novel fusion transcripts in cervical cancer cells.
McCabe MT; Powell DR; Zhou W; Vertino PM
Cancer Genet Cytogenet; 2010 Mar; 197(2):130-41. PubMed ID: 20193846
[TBL] [Abstract][Full Text] [Related]
14. PRDM1/BLIMP1: a tumor suppressor gene in B and T cell lymphomas.
Boi M; Zucca E; Inghirami G; Bertoni F
Leuk Lymphoma; 2015 May; 56(5):1223-8. PubMed ID: 25115512
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of p53 is insufficient to allow B cells and B-cell lymphomas to survive without Dicer.
Adams CM; Eischen CM
Cancer Res; 2014 Jul; 74(14):3923-34. PubMed ID: 24840646
[TBL] [Abstract][Full Text] [Related]
16. LKB1 somatic mutations in sporadic tumors.
Avizienyte E; Loukola A; Roth S; Hemminki A; Tarkkanen M; Salovaara R; Arola J; Bützow R; Husgafvel-Pursiainen K; Kokkola A; Järvinen H; Aaltonen LA
Am J Pathol; 1999 Mar; 154(3):677-81. PubMed ID: 10079245
[TBL] [Abstract][Full Text] [Related]
17. Somatic mutations in the Peutz-Jeghers (LKB1/STKII) gene in sporadic malignant melanomas.
Rowan A; Bataille V; MacKie R; Healy E; Bicknell D; Bodmer W; Tomlinson I
J Invest Dermatol; 1999 Apr; 112(4):509-11. PubMed ID: 10201537
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells.
Memmott RM; Gills JJ; Hollingshead M; Powers MC; Chen Z; Kemp B; Kozikowski A; Dennis PA
Cancer Res; 2008 Jan; 68(2):580-8. PubMed ID: 18199555
[TBL] [Abstract][Full Text] [Related]
19. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers.
Su GH; Hruban RH; Bansal RK; Bova GS; Tang DJ; Shekher MC; Westerman AM; Entius MM; Goggins M; Yeo CJ; Kern SE
Am J Pathol; 1999 Jun; 154(6):1835-40. PubMed ID: 10362809
[TBL] [Abstract][Full Text] [Related]
20. Mutation of Lkb1 and p53 genes exert a cooperative effect on tumorigenesis.
Wei C; Amos CI; Stephens LC; Campos I; Deng JM; Behringer RR; Rashid A; Frazier ML
Cancer Res; 2005 Dec; 65(24):11297-303. PubMed ID: 16357136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
